Replies to post #694 on Agraflora Ventures Ltd (AGRA)

[PotterBanker]

PUF Ventures Congratulates Cannvas MedTech on the Launch of Cannvas.Me

https://www.newswire.ca/news-releases/puf-ventures-congratulates-cannvas-medtech-on-the-launch-of-cannvasme-696285801.html



VANCOUVER, Oct. 9, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to congratulate the team at Cannvas MedTech Inc. (CSE: MTEC) (Frankfurt: 3CM) for the launch of Cannvas.Me, an unbiased educational resource for medicinal and adult-use cannabis users which is now available online at http://Cannvas.Me.

In September 2017, PUF announced the spin-off of certain assets to form a company which subsequently became Cannvas MedTech.

"I would like to congratulate Shawn Moniz and Steve Loutskou of Cannvas MedTech on the launch of their first commercial online platform," said Derek Ivany, President and CEO of PUF Ventures. "We are on the eve of legalization and the cannabis space in Canada is in need of information and education that people can trust and rely on. Using advanced technology, Shawn and Steve have built an impressive web portal that delivers physician vetted content for both medicinal and recreational cannabis users. I wish Shawn and Steve and the rest of their team the very best on a successful launch and continued growth of their remarkable web portal."

[PotterBanker]

PUF Ventures Provides Update to Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.

https://www.newswire.ca/news-releases/puf-ventures-provides-update-to-equity-participation-and-earn-in-agreement-with-delta-organic-cannabis-corp-696906601.html

VANCOUVER, Oct. 11, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to provide an update to the previously announced Equity Participation and Earn-In Agreement (the "Agreement") with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, for up to a $40 million investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, British Columbia.

PUF and DOCC have agreed to an extension to deadline for the first advance of funds by DOCC to PUF to October 17, 2018. As previously stated the completion of the transaction is subject to a number of conditions, including, but not limited to, completion of satisfactory due diligence, and the approval of the transaction by the Exchange, and the boards of directors of each of PUF and DOCC. Due to the size and complexity of the transaction, additional time is required to complete the transaction. All other terms of the contract do not change.....